Strategic Initiatives Manager
James leads strategic projects across the Nuffield Department of Clinical Neurosciences. These include the Research Excellence Framework, outside appointments/partnerships, conflict of interest, research governance, compliance, data privacy and information security, environmental sustainability, and equality, diversity and inclusivity.
James has worked in a Research Governance capacity (with the Research Governance, Ethics and Assurance Team) for University of Oxford sponsored studies, which included monitoring of clinical trials and supporting high-quality research within the University. He had previous roles at the Oxford Biomedical Research Centre and the Radiology department at the Churchill Hospital.
Prior to working in NDCN, James was a Senior Clinical Trial Manager within the Pandemic Sciences Institute, Nuffield Department of Medicine.
James is also a qualified exercise therapist and has undertaken research on the effects of exercise on the behavioural and psychological symptoms of dementia.
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.
ISARIC Clinical Characterization Group None. et al, (2022), Sci Data, 9
Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
Wainstein M. et al, (2022), PLoS Med, 19
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Leclerc QJ. et al, (2021), BMC Health Services Research, 21
The value of open-source clinical science in pandemic response: lessons from ISARIC
Abbas A. et al, (2021), The Lancet Infectious Diseases, 21, 1623 - 1624
A prenylated dsRNA sensor protects against severe COVID-19
Wickenhagen A. et al, (2021), Science, 374